|
|
CELL BIOLOGY
Agent Stops Cell Traffic at Point of Entry
May Serve as Tool for Illuminating Numerous Molecular Pathways
Life at the surface of the cell is anything but placid. Islands of receptor
proteins bob on a swirling lipid sea, waiting to attract the attention of
a messenger. Once matched, some receptor–messenger pairs disappear as
the lipid membrane suddenly invaginates and swallows them. Endocytosis, this
process by which the cell engulfs proteins, microbes, and other molecules,
has captured the attention of scientists for hundreds of years. In 1974, researchers
discovered that certain endocytic pathways depend on a remarkable three-legged
protein, clathrin. For decades, Tomas Kirchhausen, HMS professor of cell biology,
and colleagues have been helping to piece together an understanding of how
clathrin works, but there are gaps in the picture.

Photo by Graham Ramsay
Tom Kirchhausen and his colleagues are using dynasore in
the lab to explore puzzles such as how membrane traffic sends signals that
regulate cell size. They are also looking at dynamin’s role in bacterial
invasion.
Caddies in Question
It appears, for example, that clathrin molecules, aided by helper proteins,
approach the cell membrane from below and, through an astonishingly swift
and graceful sequence, mold it into a bubble-shaped vesicle. Yet the roles
of many helpers are still poorly defined. One such protein, dynamin, is
thought to play an especially important part, coming in at the end and essentially
pinching off the completed vesicle. Still, a clear picture of its comings
and goings has been lacking.
Eric Macia, Marcello Ehrlich, Ramiro Massol, Kirchhausen, and their colleagues
have stopped the protein in its tracks and report in the June 6 Developmental
Cell that dynamin plays a dual role: it detaches the completed vesicle
from
the cell membrane, but it also comes into play earlier in the process,
at the point of invagination.
What may be most exciting is the way the
researchers made their traffic-stopping discovery. Macia, Ehrlich,
and Massol, HMS research fellows in cell biology,
working with Kirchhausen and colleagues, screened a library of 16,000
compounds and found one with the ability to block dynamin activity.
They added the compound,
dynasore, to cultured human cells. Two minutes later, the cells exhibited
a complete block of endocytic traffic along the clathrin pathway. What
is more, the endocytic vesicles were frozen in two positions—either
fully formed but still attached to the plasma membrane by a small tether
or shaped
like a U, representing the kinds of half-formed pits one might see
just after invagination (see figure page 1). “That was not expected,” said
Kirchhausen, who is also a senior investigator at the CBR Institute
for Biomedical Research. “Perhaps dynamin is necessary to go beyond
the point of invagination.”
Even more surprising was how effectively
and quickly dynasore worked. “It’s
a cool reagent because you can put it in cells and, within a few minutes,
there is a nice block on the entry pathway,” Kirchhausen said. He
and his colleagues found that cells treated with dynasore rebuffed the
advances
of a variety of molecules, including transferrin, low-density lipoprotein,
and cholera toxin. When the dynamin-blocking agent was washed out,
the substances were able to enter.

Image courtesy of Tom Kirchhausen
Dynamin plays a dual role. During endocytosis, the cell membrane
invaginates (top left), forming a vesicle that breaks free and travels to
the cytoplasm (bottom left). Both of these steps are blocked by the dynamin-inhibiting
agent dynasore. Vesicles do not detach (top right). Some fail to develop past
the point of invagination (bottom right).
“This is indeed a terrific tool,” said
Venkatesh Murthy, the Morris Kahn associate professor of molecular and
cellular biology
at
Harvard University,
who was not an author on the paper. “Since the compound can rapidly
and reversibly block endocytosis, one can do experiments that may not
be possible
with knockouts or RNAi.”
An even more tantalizing approach would be to use dynasore to keep out
certain disease agents, such as cholera toxin. “There is a problem—you
would need a way to deliver this to specific cells. You might do that
topically,” said
Kirchhausen. “In my dreams, I would have a spray with dynasore
that I would use to just spritz myself if I had a flu infection. In fact,
the influenza virus
uses two paths and one of them is dependent on dynamin.”
Magic
Bullet
Catching—and stopping—dynamin in the act of vesicle
formation was something of a pipe dream until recently. Clathrin-coated
pits take a mere 20
to 60 seconds to form. Some researchers suspected dynamin might play
a role at more than one point in the process, but they had no way to
perturb, and visualize,
dynamin’s activities in real time. Two lucky events would bring
those goals within Kirchhausen’s reach.
The first occurred when
Timothy Mitchison, the Hasib Sabbagh professor of systems biology, sent
over a postdoctoral candidate, Christopher Brunner,
who happened
to be interested in membrane biology. Working with the Institute of Chemistry
and Cell Biology (ICCB), Brunner screened the nearly 16,000 compounds
and found one that blocked dynamin activity. Macia, currently at the
Centre
National
de la Recherche Scientifique in Valbonne, France, characterized the protein
and
found that it prevented dynamin from carrying out its main activity,
the hydrolysis
of GTP.
Kirchhausen mentioned to Stephen Harrison, HMS professor of biological
chemistry and molecular pharmacology, that he was looking to name the
new protein. “Steve
said, ‘Why don’t you call it dynasore?’ I said, ‘Dynasore?’ said
Kirchhausen. “‘Sore to dynamin—painful for dynamin.’ The
name just clicked.”
|
“It’s a cool reagent because you can put it in cells
and, within a few minutes, there is a nice block on the entry pathway.”
|
To test dynasore’s mettle, they decided
to see whether it could prevent the entry of dynamin-dependent proteins
in actual cells. They began with two
proteins commonly found in the body, transferrin, used for iron transport,
and low-density lipoprotein (ldl), used to carry cholesterol. Macia;
Ehrlich, currently
at Tel Aviv University in Israel; and colleagues added the proteins,
fluorescently labeled, to human cultured cells pretreated with dynasore.
Two minutes later,
the cells were washed and stained. The slides showed that the cells rejected
the transferrin and ldl proteins. Cholera toxin also enters for the most
part through clathrin-coated vesicles. Again, dynasore-treated cells
repelled the
toxin’s incursion, though not completely. “It might be taking
another route,” Kirchhausen said.
The researchers had perturbed
the nimble dynamin, but the question was how? At what stage of pit formation
had it been vulnerable to dynasore?
Over the
past
few years, thanks to the funding of a private donor, Kirchhausen had
garnered the resources to develop a method for producing time-lapse images
that
could be assembled into the form of molecular movies (see video; also
see Focus, March
7, 2003). “That
was the other lucky accident,” he said. Using the technique, the
researchers watched what happened when dynasore was added to cells with
two fluorescently
labeled vesicle proteins, clathrin and a helper, AP-2. Normally, the
fluorescent spots can be seen to undergo a complete life cycle—from
initial gathering of clathrin molecules to the formation of the clathrin
coat to its disintegration—in
20 to 60 seconds. Movies of the dynasore-treated cells revealed a very
different situation: specks of fluorescence became locked at the cell
membrane.
Judging by the degree of fluorescence, which intensifies as coat formation
proceeds, the dynamin--dependent vesicles appeared to be arrested at
two different moments—late
and early. Electron micrographs confirmed that the vesicles were stuck at two
different stages—fully formed but attached to the membrane and
U-shaped as though arrested just at the point of invagination.
How dynamin acts at each of these two points is not clear. “There are so
many models thrown out without facts,” Kirchhausen said. “We need
to go back to the molecular snapshots and understand what’s going on. There
is a whole network of interactions that we simply do not understand.” —Misia Landau
top
|